instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disorientation'. | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrolyte imbalance'. | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic cirrhosis'. | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
What is the weight of the patient? | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | 70 kg. | Weight | CC BY-NC-ND | 33790139 | 20,067,107 | 2021 |
What was the dosage of drug 'ESOMEPRAZOLE MAGNESIUM'? | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | 20 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33790139 | 20,067,107 | 2021 |
What was the outcome of reaction 'Altered state of consciousness'? | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | Recovered | ReactionOutcome | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
What was the outcome of reaction 'Coma'? | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | Recovered | ReactionOutcome | CC BY-NC-ND | 33790139 | 20,067,107 | 2021 |
What was the outcome of reaction 'Disease recurrence'? | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | Recovered | ReactionOutcome | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
What was the outcome of reaction 'Disorientation'? | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | Recovered | ReactionOutcome | CC BY-NC-ND | 33790139 | 19,201,911 | 2021 |
What was the outcome of reaction 'Hepatic encephalopathy'? | Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
The patient was a 65-year-old man with alcoholic liver cirrhosis who had been admitted to hospital 5 times for repeated and recurrent overt hepatic encephalopathy (H... | Recovered | ReactionOutcome | CC BY-NC-ND | 33790139 | 20,067,107 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Identification of Novel Alectinib-Resistant ALK Mutation G1202K with Sensitization to Lorlatinib: A Case Report and in silico Structural Modelling.
Drug resistance caused by G1202R/G1202del mutation in anaplastic lymphoma kinase (ALK) represents a great challenge in the clinic. The effect of other mutation(s) at G1202 ... | BEVACIZUMAB, DOCETAXEL | DrugsGivenReaction | CC BY-NC | 33790576 | 20,028,246 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | CISPLATIN, GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33790580 | 19,265,184 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | CISPLATIN, GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33790580 | 19,265,184 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | CISPLATIN, GEMCITABINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33790580 | 19,265,184 | 2021 |
What was the administration route of drug 'CISPLATIN'? | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 33790580 | 19,265,184 | 2021 |
What was the administration route of drug 'GEMCITABINE HYDROCHLORIDE'? | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 33790580 | 19,265,184 | 2021 |
What was the administration route of drug 'GEMCITABINE'? | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 33790580 | 19,262,728 | 2021 |
What was the administration route of drug 'GEMCITABINE\GEMCITABINE HYDROCHLORIDE'? | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 33790580 | 19,261,328 | 2021 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 33790580 | 19,262,728 | 2021 |
What was the dosage of drug 'GEMCITABINE\GEMCITABINE HYDROCHLORIDE'? | Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report.
Upper tract urothelial carcinoma (UTUC) has a high recurrence rate and is likely refractory to systemic chemotherapy. The long-term outc... | 2000 MG/M2, GIVEN ON DAYS 1 AND 8 OF EACH CYCLE | DrugDosageText | CC BY-NC | 33790580 | 19,261,328 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, LETERMOVIR, METHOTREXATE, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,292,265 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, LETERMOVIR, METHOTREXATE, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,292,265 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest pain'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, LETERMOVIR, METHOTREXATE, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,292,265 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, LETERMOVIR, METHOTREXATE, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,292,265 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection reactivation'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, LETERMOVIR, METHOTREXATE, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,292,265 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, METHOTREXATE, MYCOPHENOLATE MOFETIL, RITUXIMAB, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,815,259 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epstein-Barr virus infection'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, METHOTREXATE, MYCOPHENOLATE MOFETIL, RITUXIMAB, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,815,259 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, LETERMOVIR, METHOTREXATE, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,292,265 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraesthesia'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, LETERMOVIR, METHOTREXATE, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,292,265 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | ACYCLOVIR, CYCLOSPORINE, FLUDARABINE PHOSPHATE, FOSCARNET, GANCICLOVIR, LETERMOVIR, METHOTREXATE, THIOTEPA, TREOSULFAN, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33790588 | 19,292,265 | 2021 |
What was the administration route of drug 'ACYCLOVIR'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Oral | DrugAdministrationRoute | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the administration route of drug 'GANCICLOVIR'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the administration route of drug 'LETERMOVIR'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Oral | DrugAdministrationRoute | CC BY-NC | 33790588 | 19,292,265 | 2021 |
What was the dosage of drug 'LETERMOVIR'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | 240 MILLIGRAM DAILY; | DrugDosageText | CC BY-NC | 33790588 | 19,292,265 | 2021 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | 750 MG, TID (DAY 47) | DrugDosageText | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | 375 MG/M2/WEEK | DrugDosageText | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the dosage of drug 'VALGANCICLOVIR'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | 450 MG, BID | DrugDosageText | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the outcome of reaction 'Acute graft versus host disease in intestine'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the outcome of reaction 'Acute graft versus host disease in skin'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the outcome of reaction 'Agitation'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,292,265 | 2021 |
What was the outcome of reaction 'Asthenia'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,292,265 | 2021 |
What was the outcome of reaction 'Chest pain'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,292,265 | 2021 |
What was the outcome of reaction 'Confusional state'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,292,265 | 2021 |
What was the outcome of reaction 'Cytomegalovirus infection reactivation'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,292,265 | 2021 |
What was the outcome of reaction 'Cytomegalovirus infection'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the outcome of reaction 'Epstein-Barr virus infection'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,815,259 | 2021 |
What was the outcome of reaction 'Paraesthesia'? | Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant.
Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover,... | Recovered | ReactionOutcome | CC BY-NC | 33790588 | 19,292,265 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Perforated Acute Appendicitis in a Six-Day-Old Neonate: A Rare Differential Diagnosis of Neonatal Peritonitis.
Acute appendicitis is a rare diagnosis of acute abdomen in neonates which is associated with high mortality due to late diagnosis. Here, we presented a case of acute neonatal appendicitis in a 6-year-old full-... | AMIKACIN, CEFTRIAXONE, MEROPENEM, METRONIDAZOLE | DrugsGivenReaction | CC BY-NC | 33790704 | 19,626,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis neonatal'. | Perforated Acute Appendicitis in a Six-Day-Old Neonate: A Rare Differential Diagnosis of Neonatal Peritonitis.
Acute appendicitis is a rare diagnosis of acute abdomen in neonates which is associated with high mortality due to late diagnosis. Here, we presented a case of acute neonatal appendicitis in a 6-year-old full-... | AMIKACIN, CEFTRIAXONE, MEROPENEM, METRONIDAZOLE | DrugsGivenReaction | CC BY-NC | 33790704 | 19,626,182 | 2021 |
What is the weight of the patient? | Perforated Acute Appendicitis in a Six-Day-Old Neonate: A Rare Differential Diagnosis of Neonatal Peritonitis.
Acute appendicitis is a rare diagnosis of acute abdomen in neonates which is associated with high mortality due to late diagnosis. Here, we presented a case of acute neonatal appendicitis in a 6-year-old full-... | 3 kg. | Weight | CC BY-NC | 33790704 | 19,626,182 | 2021 |
What was the outcome of reaction 'Drug ineffective'? | Perforated Acute Appendicitis in a Six-Day-Old Neonate: A Rare Differential Diagnosis of Neonatal Peritonitis.
Acute appendicitis is a rare diagnosis of acute abdomen in neonates which is associated with high mortality due to late diagnosis. Here, we presented a case of acute neonatal appendicitis in a 6-year-old full-... | Fatal | ReactionOutcome | CC BY-NC | 33790704 | 19,626,182 | 2021 |
What was the outcome of reaction 'Sepsis neonatal'? | Perforated Acute Appendicitis in a Six-Day-Old Neonate: A Rare Differential Diagnosis of Neonatal Peritonitis.
Acute appendicitis is a rare diagnosis of acute abdomen in neonates which is associated with high mortality due to late diagnosis. Here, we presented a case of acute neonatal appendicitis in a 6-year-old full-... | Fatal | ReactionOutcome | CC BY-NC | 33790704 | 19,626,182 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 33790706 | 19,952,037 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Autoimmune haemolytic anaemia'. | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 33790706 | 20,002,578 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric polyps'. | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 33790706 | 19,952,037 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal polyp haemorrhage'. | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 33790706 | 19,952,037 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypergastrinaemia'. | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 33790706 | 19,952,037 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | RABEPRAZOLE | DrugsGivenReaction | CC BY-NC | 33790706 | 20,002,578 | 2021 |
What was the administration route of drug 'RABEPRAZOLE'? | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | Oral | DrugAdministrationRoute | CC BY-NC | 33790706 | 20,002,578 | 2021 |
What was the outcome of reaction 'Anaemia'? | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | Recovering | ReactionOutcome | CC BY-NC | 33790706 | 19,952,037 | 2021 |
What was the outcome of reaction 'Autoimmune haemolytic anaemia'? | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | Recovering | ReactionOutcome | CC BY-NC | 33790706 | 20,002,578 | 2021 |
What was the outcome of reaction 'Gastric polyps'? | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | Recovered | ReactionOutcome | CC BY-NC | 33790706 | 19,952,037 | 2021 |
What was the outcome of reaction 'Gastrointestinal polyp haemorrhage'? | Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis.
Here, we report on a rare case of gastric hyperplastic polyps which disappeared after the discontinuation of proton pump inhibitor (PPI). The patient was an 83-year-old woman with liver cir... | Recovering | ReactionOutcome | CC BY-NC | 33790706 | 19,952,037 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal infection'. | The First Two Liver Transplantations in Syria.
Liver transplantation (LT) is the only curative therapy for the end-stage liver diseases and some metabolic disorders which affect the hepatic cell like the Crigler-Najjar syndrome type 1 (CNSI). Although the LT is a routine procedure in many centers worldwide, the postope... | TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33790718 | 19,505,821 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute respiratory distress syndrome'. | The First Two Liver Transplantations in Syria.
Liver transplantation (LT) is the only curative therapy for the end-stage liver diseases and some metabolic disorders which affect the hepatic cell like the Crigler-Najjar syndrome type 1 (CNSI). Although the LT is a routine procedure in many centers worldwide, the postope... | TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33790718 | 19,505,821 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunosuppressant drug level increased'. | The First Two Liver Transplantations in Syria.
Liver transplantation (LT) is the only curative therapy for the end-stage liver diseases and some metabolic disorders which affect the hepatic cell like the Crigler-Najjar syndrome type 1 (CNSI). Although the LT is a routine procedure in many centers worldwide, the postope... | TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33790718 | 19,505,821 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | The First Two Liver Transplantations in Syria.
Liver transplantation (LT) is the only curative therapy for the end-stage liver diseases and some metabolic disorders which affect the hepatic cell like the Crigler-Najjar syndrome type 1 (CNSI). Although the LT is a routine procedure in many centers worldwide, the postope... | TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33790718 | 19,505,821 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudomonas infection'. | The First Two Liver Transplantations in Syria.
Liver transplantation (LT) is the only curative therapy for the end-stage liver diseases and some metabolic disorders which affect the hepatic cell like the Crigler-Najjar syndrome type 1 (CNSI). Although the LT is a routine procedure in many centers worldwide, the postope... | TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33790718 | 19,505,821 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Staphylococcal infection'. | The First Two Liver Transplantations in Syria.
Liver transplantation (LT) is the only curative therapy for the end-stage liver diseases and some metabolic disorders which affect the hepatic cell like the Crigler-Najjar syndrome type 1 (CNSI). Although the LT is a routine procedure in many centers worldwide, the postope... | TACROLIMUS | DrugsGivenReaction | CC BY-NC | 33790718 | 19,505,821 | 2021 |
What was the dosage of drug 'TACROLIMUS'? | The First Two Liver Transplantations in Syria.
Liver transplantation (LT) is the only curative therapy for the end-stage liver diseases and some metabolic disorders which affect the hepatic cell like the Crigler-Najjar syndrome type 1 (CNSI). Although the LT is a routine procedure in many centers worldwide, the postope... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC | 33790718 | 19,505,821 | 2021 |
What was the administration route of drug 'GLATIRAMER ACETATE'? | Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate.
Embolia cutis medicamentosa (ECM) is a rare and unpredictable injection site reaction, occurring after intramuscular, subcutaneous, and even after intraarticular injection of various drugs. We report a very rare case of necrotizing ECM af... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33790754 | 19,689,267 | 2021 |
What was the administration route of drug 'GLATIRAMER'? | Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate.
Embolia cutis medicamentosa (ECM) is a rare and unpredictable injection site reaction, occurring after intramuscular, subcutaneous, and even after intraarticular injection of various drugs. We report a very rare case of necrotizing ECM af... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33790754 | 19,660,283 | 2021 |
What was the outcome of reaction 'Injection site reaction'? | Embolia Cutis Medicamentosa after Subcutaneous Injection with Glatiramer Acetate.
Embolia cutis medicamentosa (ECM) is a rare and unpredictable injection site reaction, occurring after intramuscular, subcutaneous, and even after intraarticular injection of various drugs. We report a very rare case of necrotizing ECM af... | Recovered | ReactionOutcome | CC BY-NC | 33790754 | 19,689,267 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema annulare'. | Recurrent Erythema Annulare Centrifugum due to Influenza Type A.
Erythema annulare centrifugum (EAC) is a rare erythema characterized by erythematous and urticarial papules or annular plaques that enlarges centrifugally. The lesions usually involve the thighs and the legs. Several disorders are occasionally associated ... | ACETAMINOPHEN, TRIPROLIDINE | DrugsGivenReaction | CC BY-NC | 33790757 | 19,213,493 | 2021 |
What was the outcome of reaction 'Erythema annulare'? | Recurrent Erythema Annulare Centrifugum due to Influenza Type A.
Erythema annulare centrifugum (EAC) is a rare erythema characterized by erythematous and urticarial papules or annular plaques that enlarges centrifugally. The lesions usually involve the thighs and the legs. Several disorders are occasionally associated ... | Recovered | ReactionOutcome | CC BY-NC | 33790757 | 19,213,493 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster reactivation'. | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | ACYCLOVIR, FAMCICLOVIR, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33790759 | 19,564,069 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster'. | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | ACYCLOVIR, FAMCICLOVIR, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33790759 | 19,744,842 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection reactivation'. | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | ACYCLOVIR, FAMCICLOVIR, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33790759 | 19,744,842 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | ACYCLOVIR, FAMCICLOVIR, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33790759 | 19,744,842 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Meningitis aseptic'. | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | ACYCLOVIR, FAMCICLOVIR, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33790759 | 19,564,069 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Meningitis viral'. | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | ACYCLOVIR, FAMCICLOVIR, MYCOPHENOLIC ACID, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33790759 | 19,157,844 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | ACYCLOVIR, FAMCICLOVIR, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33790759 | 19,744,842 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Varicella zoster virus infection'. | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | ACYCLOVIR, FAMCICLOVIR, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33790759 | 19,744,842 | 2021 |
What was the administration route of drug 'FAMCICLOVIR'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Oral | DrugAdministrationRoute | CC BY-NC | 33790759 | 19,157,844 | 2021 |
What was the dosage of drug 'ACYCLOVIR'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | 750 mg (milligrams). | DrugDosage | CC BY-NC | 33790759 | 19,744,842 | 2021 |
What was the dosage of drug 'FAMCICLOVIR'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | 30 mg (milligrams). | DrugDosage | CC BY-NC | 33790759 | 19,744,842 | 2021 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | 1.5 g (grams). | DrugDosage | CC BY-NC | 33790759 | 19,744,842 | 2021 |
What was the outcome of reaction 'Herpes zoster reactivation'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Recovered | ReactionOutcome | CC BY-NC | 33790759 | 19,564,069 | 2021 |
What was the outcome of reaction 'Herpes zoster'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Recovering | ReactionOutcome | CC BY-NC | 33790759 | 19,744,842 | 2021 |
What was the outcome of reaction 'Infection reactivation'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Recovering | ReactionOutcome | CC BY-NC | 33790759 | 19,744,842 | 2021 |
What was the outcome of reaction 'Infection'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Recovering | ReactionOutcome | CC BY-NC | 33790759 | 19,744,842 | 2021 |
What was the outcome of reaction 'Meningitis aseptic'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Recovered | ReactionOutcome | CC BY-NC | 33790759 | 19,564,069 | 2021 |
What was the outcome of reaction 'Meningitis viral'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Recovered | ReactionOutcome | CC BY-NC | 33790759 | 19,157,844 | 2021 |
What was the outcome of reaction 'Rebound effect'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Recovering | ReactionOutcome | CC BY-NC | 33790759 | 19,744,842 | 2021 |
What was the outcome of reaction 'Varicella zoster virus infection'? | Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation.
Varicella zoster virus (VZV)-associated meningitis is usually progressive and can be fatal, and early diagnosis and aggressive treatment with intravenous antivirals such as acyclovir (ACV) are required in... | Recovering | ReactionOutcome | CC BY-NC | 33790759 | 19,744,842 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis'. | Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.
Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival <10% and no standard therapy. We report the first case to our knowledge of metastatic EMPD with tre... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 33790764 | 19,101,885 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.
Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival <10% and no standard therapy. We report the first case to our knowledge of metastatic EMPD with tre... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 33790764 | 19,101,885 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour pseudoprogression'. | Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.
Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival <10% and no standard therapy. We report the first case to our knowledge of metastatic EMPD with tre... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 33790764 | 19,101,885 | 2021 |
What was the dosage of drug 'IPILIMUMAB'? | Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.
Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival <10% and no standard therapy. We report the first case to our knowledge of metastatic EMPD with tre... | 1 MILLIGRAM/KILOGRAM, Q3WK | DrugDosageText | CC BY-NC | 33790764 | 19,101,885 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.